UK shareholder meetings calendar - next 7 days
22nd Apr 2025 16:58
| Price | 0.165p on 14-05-2025 at 13:44:22 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.17p |
| Sell | 0.16p |
| Buy / Sell SVNS Shares | |
| Last Trade: | Sell 72,500.00 at 0.16001p |
| Day's Volume: | 3,899,364 |
| Last Close: | 0.165p |
| Open: | 0.165p |
| ISIN: | GB00BMD1Z199 |
| Day's Range | 0.165p - 0.165p |
| 52wk Range: | 0.087p - 1.15p |
| Market Capitalisation: | £4m |
| VWAP: | 0.163809p |
| Shares in Issue: | 2,296m |
Sector: Medicine and Biotech
Solvonis Therap (SVNS) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 72,500 | 0.16001p | Ordinary |
14:44:06 - 14-May-25 |
| Sell* | 3,204,809 | 0.1644p | Ordinary |
11:20:32 - 14-May-25 |
| Sell* | 122,055 | 0.16p | Ordinary |
10:02:44 - 14-May-25 |
| Sell* | 500,000 | 0.1615p | Ordinary |
08:21:54 - 14-May-25 |
| Sell* | 73,927 | 0.163p | Ordinary |
16:27:48 - 13-May-25 |
| Sell* | 3,101,984 | 0.1613p | Ordinary |
16:24:34 - 13-May-25 |
| Sell* | 3,648,240 | 0.1612p | Ordinary |
12:29:06 - 13-May-25 |
| Unknown* | 578,873 | 0.17p | Ordinary |
12:17:58 - 13-May-25 |
| Buy* | 143,150 | 0.171p | Ordinary |
10:15:48 - 13-May-25 |
| Buy* | 1,773,711 | 0.172p | Ordinary |
09:21:25 - 13-May-25 |
Solvonis Therap (SVNS) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 28th Apr 2025 11:30 am | RNS | Result of General Meeting |
| 23rd Apr 2025 7:00 am | RNS | Proposed acquisition of Awakn approved |
| 16th Apr 2025 7:00 am | RNS | Final Results for the year ended 31 December 2024 |
| 10th Apr 2025 2:00 pm | RNS | Posting of Circular and Notice of General Meeting |
| 7th Apr 2025 7:00 am | RNS | Holding(s) in Company |
| 4th Apr 2025 7:00 am | RNS | Engagement of PharmaVentures |
| 26th Mar 2025 7:00 am | RNS | Positive progress on European Patent Application |
| 18th Mar 2025 7:00 am | RNS | Update on AWKN-SDN-14 programme |
| 11th Mar 2025 9:00 am | RNS | Holding(s) in Company |
| 11th Mar 2025 7:00 am | RNS | Appointment of Non-Executive Director |